Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
COHANCE.NSthis companyCohance Lifesciences Limited	₹443.65	64.28×	2.95×	5.08×	27.48×	-9.7%	40.2%	10.6%	7.9%	4.6%	3.3%	1.2%	0.1×	0.79×	6.44×	2.78×	0.0%	6	9.25	3	B
AAREYDRUGS.NSAarey Drugs & Pharmaceuticals Limited	₹109.04	36.51×	0.96×	0.31×	14.58×	-99.9%	3.0%	0.9%	0.8%	2.6%	1.6%	-16.1%	0.33×	3.66×	0.86×	1.81×	0.0%	6	—	2	C
ALIVUS.NSAlivus Life Sciences Limited	₹1,474.40	21.18×	3.59×	4.69×	14.44×	-46.0%	44.6%	28.3%	22.1%	16.9%	15.6%	2.2%	0.02×	0.07×	134.39×	5.21×	0.5%	—	—	4	A-
GRANULES.NSGranules India Limited	₹799.20	25.35×	2.97×	2.81×	13.13×	-42.2%	43.0%	16.6%	11.1%	11.7%	10.1%	0.8%	0.3×	0.52×	7.77×	1.8×	0.2%	5	—	2	C+
KOPRAN.NSKopran Limited	₹259.76	20.27×	0.98×	0.77×	10.71×	-111.9%	23.4%	8.9%	3.8%	4.9%	6.5%	-2.0%	0.29×	2.33×	5.77×	1.51×	2.8%	5	—	3	B-
LASA.NSLasa Supergenerics Limited	₹4.22	-0.83×	0.57×	1.13×	-1.34×	-306.6%	-27.4%	-53.2%	-135.6%	-68.7%	-22.1%	0.0%	0.2×	-0.34×	-34.66×	0.62×	0.0%	2	—	2	C
Peer median	—	21.18×	0.98×	1.13×	13.13×	-99.9%	23.4%	8.9%	3.8%	4.9%	6.5%	0.0%	0.29×	0.52×	5.77×	1.8×	0.2%	5	—	2	—